Project Number EUJPND-BC|CQDM|OBI-Yoganathan-355 Agency/Funding Organization Brain Canada|Quebec Consortium for Drug Discovery Funding Year 2016 View Full Project Details for Drug Delivery across the Human Blood-Brain Barrier Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 1. Research Resources and Enabling Technologies to Accelerate Therapy Development a. Enabling Technologies Researcher and Organization Principal Investigator Yoganathan, Nathan Principal Investigator First Name Nathan Principal Investigator Last Name Yoganathan Awardee Organization KalGene Pharm. Contact PI Country Canada Project Detail FY Overall Cost $332,622 Funding Organization Agency/Funding Organization Brain Canada|Quebec Consortium for Drug Discovery Funding Organization Country Canada Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
